Denali Therapeutics Inc.
DNLI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001714899
In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Denali Therapeutics Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 195
- −6 vs. Q2 2023
- Shares held
- 108.6M
- +2.04M (+1.9%) vs. Q2 2023
- Total value
- $2.24B
- −$898.3M (−28.6%) vs. Q2 2023
- New holders
- 29
- 77 more added
- Sold out
- 35
- 57 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 294 | $4.00B |
| Q1 2026 | 269 | $2.82B |
| Q4 2025 | 250 | $2.50B |
| Q3 2025 | 240 | $1.97B |
| Q2 2025 | 231 | $1.93B |
| Q1 2025 | 222 | $1.85B |
| Q4 2024 | 224 | $2.61B |
| Q3 2024 | 217 | $3.69B |
| Q2 2024 | 203 | $2.88B |
| Q1 2024 | 211 | $2.51B |
| Q4 2023 | 209 | $2.47B |
| Q3 2023 | 195 | $2.24B |
| Q2 2023 | 203 | $3.18B |
| Q1 2023 | 202 | $2.49B |
| Q4 2022 | 199 | $2.94B |
| Q3 2022 | 200 | $2.84B |
| Q2 2022 | 188 | $2.73B |
| Q1 2022 | 190 | $2.79B |
| Q4 2021 | 213 | $3.80B |
| Q3 2021 | 214 | $4.28B |
| Q2 2021 | 210 | $6.32B |
| Q1 2021 | 218 | $4.60B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Denali Therapeutics Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| University of Texas/Texas Am Investment Managment Co | 0 | $0 | 0.00% | −36,513−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −36,444−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −35,549−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −34,400−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −31,611−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −28,040−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −26,642−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −26,400−100.0% | Sold out |
| Linden Thomas Advisory Services, LLC | 0 | $0 | 0.00% | −19,597−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −19,594−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −16,097−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −12,478−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,788−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −10,465−100.0% | Sold out |
| Brandywine Managers, LLC | 0 | $0 | 0.00% | −9,601−100.0% | Sold out |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 0 | $0 | 0.00% | −9,033−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −8,898−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −8,888−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −8,391−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −8,307−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −8,165−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −7,578−100.0% | Sold out |
| Pitcairn Co | 0 | $0 | 0.00% | −7,051−100.0% | Sold out |
| Xponance, Inc. | 0 | $0 | 0.00% | −6,963−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −6,878−100.0% | Sold out |
| Tao Capital Management LP | 0 | $0 | 0.00% | −3,651−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| VitalStone Financial, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Tekla Capital Management LLC | – | – | – | – | Not filed |